Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-06-14 23:40:00
Oslo, Norway, June 14, 2021 - Vaccibody AS, a clinical-stage biopharmaceutical
company dedicated to the discovery and development of vaccines and novel
immunotherapies, announced that 100,000 share options have been granted to
Katrine Husum in connection with her appointment as Director Project and
Alliance Management. The share options will have a strike price of NOK 69.58 per
share, vest in four equal tranches on February 1 each year and expire February
1, 2026. After the award of the share options, Katrine Husum holds a total of
100,000 share options and 0 shares.
Please see further details in attached document.